Deep-brain stimulation of the human nucleus accumbens-medial septum enhances memory formation.


Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
20 Nov 2023
Historique:
pubmed: 4 12 2023
medline: 4 12 2023
entrez: 4 12 2023
Statut: epublish

Résumé

Deep-brain stimulation (DBS) is a potential novel treatment for memory dysfunction. Current attempts to enhance memory focus on stimulating human hippocampus or entorhinal cortex. However, an alternative strategy is to stimulate brain areas providing modulatory inputs to medial temporal memory-related structures, such as the nucleus accumbens (NAc), which is implicated in enhancing episodic memory encoding. Here, we show that NAc-DBS improves episodic and spatial memory in psychiatric patients. During stimulation, NAc-DBS increased the probability that infrequent (oddball) pictures would be subsequently recollected, relative to periods off stimulation. In a second experiment, NAc-DBS improved performance in a virtual path-integration task. An optimal electrode localization analysis revealed a locus spanning postero-medio-dorsal NAc and medial septum predictive of memory improvement across both tasks. Patient structural connectivity analyses, as well as NAc-DBS-evoked hemodynamic responses in a rat model, converge on a central role for NAc in a hippocampal-mesolimbic circuit regulating encoding into long-term memory. Thus, short-lived, phasic NAc electrical stimulation dynamically improved memory, establishing a critical on-line role for human NAc in episodic memory and providing an empirical basis for considering NAc-DBS in patients with loss of memory function.

Identifiants

pubmed: 38045279
doi: 10.21203/rs.3.rs-3476665/v1
pmc: PMC10690315
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH113929
Pays : United States

Déclaration de conflit d'intérêts

COMPETING FINANCIAL INTERESTS J.A.B. reports having received research funding from Boston Scientific and Medtronic. C.N. has received funding from Boston Scientific Ibéria. The authors declare no other competing financial interests.

Auteurs

Svenja Treu (S)

Laboratory for Clinical Neuroscience, Centre for Biomedical Technology, Universidad Politécnica de Madrid, Spain.

Juan A Barcia (JA)

Department of Neurosurgery, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos, Universidad Complutense de Madrid, Spain.

Cristina Torres (C)

Department of Neurosurgery, University Hospital La Princesa, Madrid, Spain.

Anne Bierbrauer (A)

Institute of Systems Neuroscience, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf (UKE), Germany.

Javier J Gonzalez-Rosa (JJ)

Departament of Psychology, University of Cadiz, Institute of Biomedical Research Cadiz (INiBICA), Cádiz, Spain.

Cristina Nombela (C)

Department of Neurosurgery, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos, Universidad Complutense de Madrid, Spain.
Departamento de Psicología Biológica y de la Salud, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid, Spain.

Jose A Pineda-Pardo (JA)

HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.

Daniel Torres (D)

Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas & Universidad Miguel Hernández, Sant Joan d'Alacant, Spain.

Lukas Kunz (L)

Department of Biomedical Engineering, Columbia University, New York, NY, USA.

Robin Hellerstedt (R)

Laboratory for Clinical Neuroscience, Centre for Biomedical Technology, Universidad Politécnica de Madrid, Spain.

Josue M Avecillas-Chasin (JM)

Department of Neurosurgery, University of Nebraska Medical Center, Omaha, NE, USA.
Department of Neurosurgery, University of California Los Angeles, Los Angeles, CA, USA.

Monica Lara (M)

Department of Neurosurgery, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.

Marta Navas (M)

Department of Neurosurgery, University Hospital La Princesa, Madrid, Spain.

Ana Galarza Vallejo (AG)

Laboratory for Clinical Neuroscience, Centre for Biomedical Technology, Universidad Politécnica de Madrid, Spain.

Julia García-Albea (J)

Department of Psychiatry, Hospital Clínico San Carlos (IdISSC), CIBERSAM, Universidad Complutense de Madrid, Spain.

Antonio Oliviero (A)

Hospital Nacional de Parapléjicos, FENNSI Group, Toledo, Spain.

Fernando Seijo (F)

Centro Medico Asturias, Oviedo, Spain.

Andreas Horn (A)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology, 10117 Berlin, Germany.
Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston MA 02115, USA.
MGH Neurosurgery & Center for Neurotechnology and Neurorecovery (CNTR) at MGH Neurology Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Ningfei Li (N)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology, 10117 Berlin, Germany.

Nikolai Axmacher (N)

Department of Neuropsychology, Institute of Cognitive Neuroscience, Faculty of Psychology, Ruhr University Bochum, Germany.

Santiago Canals (S)

Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas & Universidad Miguel Hernández, Sant Joan d'Alacant, Spain.

Blanca Reneses (B)

Department of Psychiatry, Hospital Clínico San Carlos (IdISSC), CIBERSAM, Universidad Complutense de Madrid, Spain.

Bryan A Strange (BA)

Laboratory for Clinical Neuroscience, Centre for Biomedical Technology, Universidad Politécnica de Madrid, Spain.
Department of Neuroimaging, Alzheimer's Disease Research Centre, Reina Sofia-CIEN Foundation, Madrid, Spain.

Classifications MeSH